Many cardiovascular events develop in postmenopausal women. Heart disease occurs in females on average ten years later than males, which is associated with the protective effects of female sex hormones, especially estrogens, before menopause (
26). We evaluated the effect of six weeks of HIIT and soy IF treatment on the microRNA-133 expression in ovariectomized rat’ heart. It was hypothesized that ovariectomy van induce apoptosis and a pathological cardiac gene expression pattern. In addition, the HIIT training and soy IF administration alone or in combination would lead to upregulation of cardiac anti‐apoptotic gene.
Down‐regulation of microRNA‐133 cardiac expression in ovariectomized animals was linked to anti‐apoptosis compared to the SHAM surgery rats. Six weeks of HIIT training increased the expression of the microRNA‐133 gene. The expression of the microRNA‐133 gene increased by eight weeks of soy IF administration. Combining soy IF supplementation and regular HIIT training has no significant cardiac protective effect compared to employing either strategy alone. Our results suggested that the ovariectomy model successfully reduced microRNA-133 expression, indicating an association between rodent vascular function and such menopause model. These results are consistent with those of (
19,
23).
The mean weight of the ovariectomized rats increased significantly compared to the SHAM group. Our findings are in line with those found in previous reports showing that weight gain in postmenopausal women is connected to estrogen deficiency, increased visceral fat, and inflammation of metabolic disorders (
27-
29). This process occurs through interference with leptin, which is known as a hormone for producing adipose cells and plays a vital role in regulating body weight and appetite (
30). Studies have shown that estrogen supplementation reduces food intake and body weight after menopause. The estrogen receptor alpha has adjusted the effect that has been proposed. Additionally, estrogen plays an essential role in reducing body composition through the reduced accumulation of fatty acids, triglyceride synthesis, and lipogenesis (
31).
Isoflavones are phytochemicals present in many legumes as a large group of non-steroidal materials with various structures obtained from plants attached to estrogen receptors (ERs) in humans and animals. Isoflavones exhibit have more tendency for ER-A compared to ER-> and have estrogen antagonist and estrogen-agonist characteristics. The biochemical genistein, glycitein, formononetin daidzein, and biochanin A are some IFs. Daidzein and genistein are highly found in soybeans and soy products and red clover, kudzu, and the American groundnut (
32). Recent systematic review and meta-analysis suggested that soy IFs decreased serum total cholesterol levels in postmenopausal women (
33).
In the present investigation, microRNA-133 was markedly down‐regulated in cardiomyocytes from OVX rats’ heart compared to the SHAM group. Such findings are consistent with previous reports (
19,
34), which states that ovariectomy down‐regulated Mir‐133 expression levels in the cardiac tissue. The OVX-induced increase in genes that mediate inflammation (IL-6, inhibin beta, TNF-alpha, SOCS3, and SOCS2), an OVX-induced reduction in the myocardial mRNA expression of genes are associated with regulating vasodilation (soluble guanyl cyclase and endothelial NOS), an OVX-related elevation in extracellular matrix genes (alpha1, collagen12, connexin 43), and an OVX-induced elevation in proapoptotic genes (calpain and caspase 3).
We also showed that HIIT improve the expression of microRNA-133 in ovariectomized rats’ heart. Interestingly, HIIT has a more significant cardio protective effect than the other treatment groups. MicroRNAs are mediators of processes involved in adaptation to exercise training, such as cardiac (
35) and skeletal muscle (
36). Also, vastus lateralis of healthy individuals were found with significant up-regulation of hsa-miR-133a and hsa-miR-1 expression levels against cycle ergometer exercise bout at 65% of Pmax (
37). In addition, a 12-week aerobic exercise on a cycle ergometer decreased the hsa-miR-133a, hsa-miR-1, hsa-miR-206and hsa-miR-133b. Greater microRNA-133 activity in cardiac muscle of rat models reduced caspase‐3 and caspase‐9 with H
2O
2 (
38), decreased malondialdehyde (MDA) and reactive oxygen species (ROS) levels and increased glutathione peroxidase (GPx) levels and superoxide dismutase (SOD) activity to protect the heart against apoptosis (
34). We showed the soy IF supplementation as a probable modality for decreasing ovariectomy-related alterations in this cardiac gene expression. Also, six weeks of soy IF administration increased the expression of microRNA-133 in ovariectomized rats.
These findings were consistent with the results obtained by other human-based studies, based on which soybean IF administration could benefit lipid metabolism and aerobic exercise performance (
39) and cardiovascular disease risk factors in menopausal female cases by the modulation of hepatic protein expression profiles (
40). Furthermore, previous studies have shown that soy IF supplementation increase cardiometabolic benefits for postmenopausal women and activates peroxisome proliferator-activated receptors (PPARγ)-related signal transduction pathways, modulating adipogenesis, lipogenesis, and lipolysis (
41). Isoflavones have anti-estrogenic and estrogenic activities, associated with their level, the level of endogenous sex hormones, and the involved organ. The present could not show a more significant cardiac protective effect of combining soy IF supplementation and regular HIIT than employing either strategy alone. Future study should determine whether our investigations on microRNA-133 expression translate into assessable physiological impacts on cardiac function, especially skeletal muscle.
5.1. Conclusions
The results supported the beneficial effects of HIIT and/or soy IF administration on the microRNA-133 actions to enhance the cardiac function. Furthermore, we could speculate that HIIT administration can provide an effective cardioprotective in a menopause rat model than soy supplementation or their combination.